DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells - PubMed

Affiliations

• PMID: 18591936
• DOI: 10.1038/onc.2008.203

DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells

E García-Aragoncillo et al. Oncogene. 2008.

Abstract

The molecular hallmark of the Ewing's family of tumors is the presence of balanced chromosomal translocations, leading to the formation of chimerical transcription factors (that is, EWS/FLI1) that play a pivotal role in the pathogenesis of Ewing's tumors by deregulating gene expression. We have recently demonstrated that DAX1 (NR0B1), an orphan nuclear receptor that was not previously implicated in cancer, is induced by the EWS/FLI1 oncoprotein and is highly expressed in Ewing's tumors, suggesting that DAX1 is a biologically relevant target of EWS/FLI1-mediated oncogenesis. In this study we demonstrate that DAX1 is a direct transcriptional target of the EWS/FLI1 oncoprotein through its binding to a GGAA-rich region in the DAX1 promoter and show that DAX1 is a key player of EWS/FLI1-mediated oncogenesis. DAX1 silencing using an inducible model of RNA interference induces growth arrest in the A673 Ewing's cell line and severely impairs its capability to grow in semisolid medium and form tumors in immunodeficient mice. Gene expression profile analysis demonstrated that about 10% of the genes regulated by EWS/FLI1 in Ewing's cells are DAX1 targets, confirming the importance of DAX1 in Ewing's oncogenesis. Functional genomic analysis, validated by quantitative RT-PCR, showed that genes implicated in cell-cycle progression, such as CDK2, CDC6, MCM10 or SKP2 were similarly regulated by EWS/FLI1 and DAX1. These findings indicate that DAX1 is important in the pathogenesis of the Ewing's family of tumors, identify new functions for DAX1 as a cell-cycle progression regulator and open the possibility to new therapeutic approaches based on DAX1 function interference.

Similar articles

• Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.

  Carrillo J, García-Aragoncillo E, Azorín D, Agra N, Sastre A, González-Mediero I, García-Miguel P, Pestaña A, Gallego S, Segura D, Alonso J. Carrillo J, et al. Clin Cancer Res. 2007 Apr 15;13(8):2429-40. doi: 10.1158/1078-0432.CCR-06-1762. Clin Cancer Res. 2007. PMID: 17438102

• GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.

  Luo W, Gangwal K, Sankar S, Boucher KM, Thomas D, Lessnick SL. Luo W, et al. Oncogene. 2009 Nov 19;28(46):4126-32. doi: 10.1038/onc.2009.262. Epub 2009 Aug 31. Oncogene. 2009. PMID: 19718047

• EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.

  Tanaka K, Iwakuma T, Harimaya K, Sato H, Iwamoto Y. Tanaka K, et al. J Clin Invest. 1997 Jan 15;99(2):239-47. doi: 10.1172/JCI119152. J Clin Invest. 1997. PMID: 9005992 Free PMC article.

• Context matters: the hen or egg problem in Ewing's sarcoma.

  Kovar H. Kovar H. Semin Cancer Biol. 2005 Jun;15(3):189-96. doi: 10.1016/j.semcancer.2005.01.004. Semin Cancer Biol. 2005. PMID: 15826833 Review.

• Regulation of apoptosis and proliferation in Ewing's sarcoma--opportunities for targeted therapy.

  Kontny U. Kontny U. Hematol Oncol. 2006 Mar;24(1):14-21. doi: 10.1002/hon.766. Hematol Oncol. 2006. PMID: 16400699 Review.

Cited by

• The TET family of proteins: functions and roles in disease.

  Tan AY, Manley JL. Tan AY, et al. J Mol Cell Biol. 2009 Dec;1(2):82-92. doi: 10.1093/jmcb/mjp025. Epub 2009 Sep 24. J Mol Cell Biol. 2009. PMID: 19783543 Free PMC article. Review.

• MCM10: one tool for all-Integrity, maintenance and damage control.

  Thu YM, Bielinsky AK. Thu YM, et al. Semin Cell Dev Biol. 2014 Jun;30:121-30. doi: 10.1016/j.semcdb.2014.03.017. Epub 2014 Mar 21. Semin Cell Dev Biol. 2014. PMID: 24662891 Free PMC article. Review.

• YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model.

  Minas TZ, Han J, Javaheri T, Hong SH, Schlederer M, Saygideğer-Kont Y, Çelik H, Mueller KM, Temel I, Özdemirli M, Kovar H, Erkizan HV, Toretsky J, Kenner L, Moriggl R, Üren A. Minas TZ, et al. Oncotarget. 2015 Nov 10;6(35):37678-94. doi: 10.18632/oncotarget.5520. Oncotarget. 2015. PMID: 26462019 Free PMC article.

• Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response.

  Pondugula SR, Mani S. Pondugula SR, et al. Cancer Lett. 2013 Jan 1;328(1):1-9. doi: 10.1016/j.canlet.2012.08.030. Epub 2012 Aug 29. Cancer Lett. 2013. PMID: 22939994 Free PMC article. Review.

• Mcm10: A Dynamic Scaffold at Eukaryotic Replication Forks.

  Baxley RM, Bielinsky AK. Baxley RM, et al. Genes (Basel). 2017 Feb 17;8(2):73. doi: 10.3390/genes8020073. Genes (Basel). 2017. PMID: 28218679 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • NIAID Data Ecosystem - Find datasets on Infectious and Immune-mediated Diseases

• Miscellaneous

  • NCI CPTAC Assay Portal